All Infectious Disease articles – Page 5
-
NewsFast, accurate, low-cost diagnostics - and no lab required
Researchers have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease. The test uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.
-
NewsSeventy-year-old Parkinson’s drug shows promise against tuberculosis
A medication developed in the 1950s to treat Parkinson’s disease may offer a powerful new tool in the fight against tuberculosis. The study found that benztropine can dramatically reduce levels of TB-causing bacteria by boosting the body’s natural immune response.
-
NewsScientists trace the evolution of the H5N1 virus
Researchers have discovered that the currently circulating 2.3.4.4b clade of H5N1 has specific mutations in its genome that increase its human adaptive potential.
-
NewsStudy: Long COVID remains a substantial financial and medical burden
Individuals with long COVID-19 experienced worse financial and employment outcomes – lasting up to three years after their initial infection. Notably, vaccination against COVID-19 was associated with strikingly improved work and financial outcomes.
-
NewsWhat exactly is Long COVID? It depends who you ask
New research finds that the definition of Long COVID varies so widely across published studies that the percentage of people identified as having the condition can differ dramatically, making it harder to treat patients and advance research.
-
NewsMultidrug-resistant bacteria spread from war-zone hospitals to other countries
After Russia’s full-scale invasion, thousands of patients were transferred from Ukraine to other European countries. Researchers in Helsinki found that 8% of Ukrainian refugees had been hospitalised due to war injuries. Almost 80% of them carried multidrug resistant bacteria.
-
NewsResearchers discover all-new antifungal drug candidate in university greenhouse
A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections. The new molecules, dubbed coniotins, were isolated from a plant-dwelling fungus called Coniochaeta hoffmannii — the samples of which were collected from the McMaster ...
-
NewsResearchers identify a potential biomarker for long COVID
Researchers have identified a potential biomarker for long COVID. The study results detail the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) — tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials.
-
NewsGlobal Virus Network reaffirms support for mRNA vaccines and collaborative vaccine research
The Global Virus Network (GVN) has announced that it is unequivocally committed to the continued development and deployment of mRNA vaccines and the global scientific collaboration that makes such innovation possible.
-
NewsMalaria vaccine mimics natural immunity with high precision
A detailed analysis reveals one of the reasons why the R21/Matrix-M malaria vaccine works so well: the antibodies generated following vaccination are indistinguishable from those found in people who have been infected by the parasites.
-
NewsLab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon
Groundbreaking research has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.
-
NewsChemical trick could turn losing malaria drug into a winner
A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. Chemists have remodeled their structures to make them more soluble, while maintaining their effectiveness against drug-resistant parasites.
-
News4,000-year-old sheep reveals that livestock played a role in prehistoric plague infections
An ancient Yersinia pestis genome recovered from sheep sheds new light on a mysterious infectious disease that plagued prehistoric Eurasia for over 2000 years.
-
NewsFighting infections with the power of the microbiome
Scientists have discovered that bacteria of the species Klebsiella oxytoca can displace pathogenic bacteria from the gut and want to develop a living biotherapeutic based on this finding. The DZIF is now providing 2.2 million euros in funding for product development.
-
NewsEarly challenges to the immune system disrupt oral health
Researchers identified changes over time in the oral microbiome of children living with HIV, offering insights into how early immune challenges shape not only oral health but also systemic health.
-
NewsKenya achieves elimination of human African trypanosomiasis as a public health problem
The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone.
-
NewsNew network to address malaria among school-aged children in sub-Saharan Africa
A new network aims to improve malaria prevention among school-aged children in sub-Saharan Africa. The new partnership will unite researchers, policymakers, healthcare practitioners and other stakeholders across multiple countries to better understand and address the burden of malaria in children.
-
NewsNovel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
Non-pharmaceutical interventions such as masking and distancing targeted towards SARS-CoV-2 during the pandemic also decreased circulation rates of and population immunity to common respiratory pathogens in children, a new study shows.
-
NewsNational study urges expanded vaccine screening in emergency departments
About 49% of people are unaware of one or more vaccines recommended for them. Further, 86% have not received one or more of these vaccines, according to the first national comprehensive vaccine surveillance study conducted in emergency departments.
-
NewsRevealed: New vaccine target to block malaria transmission
Researchers have visualised a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.